Longhorn Vaccines and Diagnostics Collaborates with Institute of Agrifood Research and Technology on Research to Inactivate Swine Fever During Sample Collection Process
Research presented in a poster session at the Epizone Conference in Uppsala, Sweden September 25-27, 2024
Bethesda, MD and Gaithersburg, MD, September 30, 2024 – Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, is working with scientists from the World Organization of Animal Health (WOAH) Reference Laboratory for Classical Swine Fever in Barcelona, Spain to report on effective inactivation of classical swine fever virus (CSFV) in laboratory and clinical samples using PrimeStore® MTM. The results were presented in a poster at the Epizone Conference in Uppsala, Sweden, which took place September 25-27, 2024.
The Institute of Agrifood Research and Technology’s Centre de Recerca en Sanitat Animal (IRTA-CReSA) researchers conducted the study in collaboration with Longhorn. The study demonstrated complete inactivation of CSFV in laboratory culture samples as well as in clinical samples from infected pigs while maintaining nucleic acid integrity to allow detection by PCR following inactivation. Additionally, nucleic acid integrity was maintained in samples stored for 60 days at room temperature and 4o C.
CSFV is one of the most important diseases of swine, being flagged to the WOAH. Longhorn Senior VP of Animal Health Jerry Torrison, D.V.M. noted, “This work is a significant addition to the portfolio of research documenting the value of PrimeStore® MTM for safe handling of samples used for diagnosing high consequence diseases. This is an important tool for reducing the risks and costs associated with shipping, processing and storing diagnostic samples and reference materials.”
The poster authors include Adriana Muñoz-Aguilera, Xavier Abad, Cristina Riquelme, Iván Muñoz, Liani Coronado, Rosa Rosell and Llilianne Ganges from IRTA-CReSA in Barcelona, Spain, and Christopher Helm and Jerry Torrison from Longhorn in Bethesda, Maryland.
EPIZONE European Research Group is the international network of veterinary research institutes working on epizootic animal diseases including those which may have zoonotic potential. It plays a key role in research on prevention, detection and control of animal diseases and zoonoses in order to reduce the risks and harm to animal health and the risks to public health in the EU and beyond.
About Longhorn Vaccines and Diagnostics
Longhorn Vaccines and Diagnostics is a closely held One Health company based in Maryland that is developing broad coverage vaccines and diagnostic tools for worldwide public health concerns such as anti-microbial resistance, sepsis and to prevent future pandemics. Since its inception in 2006, Longhorn has focused on developing broad coverage vaccines and diagnostic tools that can impact a pandemic on a global scale and at all socio-economic levels. Since pandemics flow between humans and animals, Longhorn products play a significant role to surveil, diagnose, prevent and treat the next infectious disease.
Longhorn’s core product, PrimeStore® Molecular Transport Medium (MTM), is a patented, FDA cleared, state-of-the-art ambient temperature molecular diagnostic collection and transport device that can help governments, global health organizations, and drug manufacturers improve the diagnosis and treatment of highly infectious diseases such as Influenza, SARS-CoV-2, and Mycobacterium tuberculosis (TB). Unlike standard devices for collecting and transporting virus samples, PrimeStore® MTM is the first molecular transport device that can safely deactivate pathogens and stabilize RNA and DNA, allowing enhanced point of care and ambient temperature transport for laboratory based molecular testing and characterization.
Contacts
Longhorn Vaccines and Diagnostics LLC
Jeffrey Fischer
Email: jeff@lhnvd.com
Media
Alexis Feinberg – ICR Westwicke PR
Email: alexis.feinberg@westwicke.com
###
